Chiffres en millions de dollars américains. L'exercice financier va de février à janvier.
Breakdown
TTM
12/31/2025
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Revenus
24
24
28
24
14
9
Croissance des revenus (H/H)
-14%
-14%
17%
71%
56%
-36%
Coût des ventes
8
8
10
11
3
-1
Bénéfice brut
15
15
18
13
11
10
Vente, Général et Administration
7
7
10
8
9
7
Recherche et développement
--
--
--
--
--
--
Frais d'exploitation
22
22
17
18
21
22
Autres revenus (charges) non opérationnels
--
0
0
--
--
0
Bénéfice avant impôts
-7
-7
0
-4
-8
-7
Charge d'impôt sur le revenu
--
--
--
--
--
--
Bénéfice net
-7
-7
0
-4
-8
-7
Croissance du bénéfice net
--
--
-100%
-50%
14%
-22%
Actions en circulation (diluées)
16.44
16.44
16.44
14.04
14.04
14.04
Variation des actions (H-H)
0%
0%
17%
0%
0%
0%
EPS (dilué)
-0.43
-0.43
0.02
-0.32
-0.62
-0.57
Croissance du EPS
-2,266%
-2,281%
-106%
-48%
9%
-11%
Flux de trésorerie libre
-8
-12
-8
-5
-9
-12
Flux de trésorerie libre par action
--
--
--
--
--
--
Marge brute
62.5%
62.5%
64.28%
54.16%
78.57%
111.11%
Marge opérationnelle
-29.16%
-29.16%
0%
-20.83%
-71.42%
-122.22%
Marge bénéficiaire
-29.16%
-29.16%
0%
-16.66%
-57.14%
-77.77%
Marge du flux de trésorerie libre
-33.33%
-50%
-28.57%
-20.83%
-64.28%
-133.33%
EBITDA
-7
-7
0
-5
-10
-11
Marge EBITDA
-29.16%
-29.16%
0%
-20.83%
-71.42%
-122.22%
D&A pour le résultat opérationnel
0
0
0
0
0
0
EBIT
-7
-7
0
-5
-10
-11
Marge EBIT
-29.16%
-29.16%
0%
-20.83%
-71.42%
-122.22%
Taux d'imposition effectif
--
--
--
--
--
--
Statistiques clés
Clôture préc.
$0.51
Prix d'ouverture
$1.05
Plage de la journée
$0.51 - $1.05
Plage de 52 semaines
$0.51 - $1.05
Volume
100
Volume moyen
0
Rendement en dividend
--
BPA (TTM)
-0.03
Capitalisation boursière
$8.3M
Qu’est-ce que REDSENSE MEDICAL AB ?
Redsense Medical AB engages in the development and manufacturing of blood loss detection devices. The company is headquartered in Halmstad, Hallands and currently employs 4 full-time employees. The company went IPO on 2015-06-17. The firm is active within the field of hemodialysis. The company operates as a manufacturer of blood loss detection device that is designed to alarm on blood leakage from the venous blood access. The firm's Redsense system consists of an alarm unit, an extension fiber and a non invasive sensor patch. When the sensor patch is placed over the blood access, it detects any blood coming in contact with the sensor. This can occur if the needle is accidentally dislodged or if blood is leaking during dialysis. The Redsense system is designed to alarm when blood reaches the sensor, so the dialysis caregiver or observing person at home, can apply appropriate action when a venous needle dislodges.
